Swedbank AB Has $9.01 Million Stock Holdings in Solventum Corporation $SOLV

Key Points

• Swedbank AB increased its position in Solventum Corporation by 15.9%, owning 118,496 shares worth approximately $9.01 million at the end of the quarter.
• Solventum reported $1.69 EPS for the last quarter, surpassing analysts' expectations, with a revenue of $2.16 billion, reflecting a year-over-year growth of 3.8%.
• Research firms have mixed ratings for Solventum, with four analysts issuing a "Buy" rating, six giving it a "Hold," and one a "Sell," while the average price target is currently around $85.44.

Swedbank AB grew its stake in shares of Solventum Corporation (NYSE:SOLV - Free Report) by 15.9% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 118,496 shares of the company's stock after acquiring an additional 16,233 shares during the period. Swedbank AB owned 0.07% of Solventum worth $9,010,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Banque Transatlantique SA grew its holdings in shares of Solventum by 9,219.8% during the 1st quarter. Banque Transatlantique SA now owns 59,274 shares of the company's stock valued at $4,165,000 after acquiring an additional 58,638 shares in the last quarter. Concurrent Investment Advisors LLC acquired a new position in Solventum during the 1st quarter worth $216,000. Jones Financial Companies Lllp lifted its position in Solventum by 3,484.6% during the 1st quarter. Jones Financial Companies Lllp now owns 120,656 shares of the company's stock worth $9,175,000 after acquiring an additional 117,290 shares during the last quarter. Bessemer Group Inc. lifted its position in Solventum by 17.1% during the 1st quarter. Bessemer Group Inc. now owns 1,963 shares of the company's stock worth $150,000 after acquiring an additional 287 shares during the last quarter. Finally, Comerica Bank lifted its position in Solventum by 39.7% during the 1st quarter. Comerica Bank now owns 77,725 shares of the company's stock worth $5,910,000 after acquiring an additional 22,079 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on SOLV shares. Wall Street Zen lowered shares of Solventum from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, September 9th. Argus raised shares of Solventum from a "hold" rating to a "buy" rating and set a $90.00 price objective for the company in a research report on Tuesday, July 1st. Morgan Stanley raised shares of Solventum from an "equal weight" rating to an "overweight" rating and upped their price objective for the company from $80.00 to $103.00 in a research report on Tuesday, July 15th. Zacks Research raised shares of Solventum from a "hold" rating to a "strong-buy" rating in a research report on Monday, September 15th. Finally, KeyCorp initiated coverage on shares of Solventum in a research report on Friday, June 6th. They issued a "sector weight" rating for the company. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $85.44.

Solventum Stock Performance

Shares of SOLV stock traded down $0.60 on Friday, reaching $73.77. The stock had a trading volume of 1,491,907 shares, compared to its average volume of 1,021,429. The company has a quick ratio of 0.86, a current ratio of 1.22 and a debt-to-equity ratio of 2.14. The firm's 50-day moving average is $72.98 and its two-hundred day moving average is $72.41. The firm has a market capitalization of $12.79 billion, a price-to-earnings ratio of 34.15, a P/E/G ratio of 3.03 and a beta of 0.53. Solventum Corporation has a 12 month low of $60.70 and a 12 month high of $85.92.

Solventum (NYSE:SOLV - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $1.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.45 by $0.24. Solventum had a net margin of 4.52% and a return on equity of 29.93%. The company had revenue of $2.16 billion for the quarter, compared to analysts' expectations of $2.12 billion. During the same period in the prior year, the firm earned $1.56 EPS. Solventum's quarterly revenue was up 3.8% compared to the same quarter last year. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. On average, research analysts expect that Solventum Corporation will post 6.58 EPS for the current fiscal year.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.